Status:
COMPLETED
Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Vaso-occlusive Crisis
Sickle Cell Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The management of pain in the emergency department is a major issue, especially for sickle cell patients who regularly consult for vaso-occlusive seizure (VOS). The place of virtual reality remains to...
Detailed Description
It will be a Before-after study: this study will be conducted in 2 phases in the emergency department * a period of usual management of sickle cell patients with VOS * then a phase during which the d...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- sickle cell patient consulting in the emergency room for VOS
- Signature free and informed consent
Exclusion
- Consultation in the ER for the same reason in the 14 days prior to inclusion (same episode)
- Emergency room consultation more than 12 times in the previous year
- Nausea and vomiting at the time of inclusion
- History of epilepsy
- A visually impaired or hard of hearing patient
- Pregnant patient
- Previous inclusion in the study
Key Trial Info
Start Date :
March 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 2 2021
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT04756375
Start Date
March 4 2021
End Date
September 2 2021
Last Update
October 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HOPITAL TENON Service des urgences
Paris, France, 75020